H.B. Fuller Company (FUL)
| Market Cap | 3.00B -8.1% |
| Revenue (ttm) | 3.51B -0.6% |
| Net Income | 185.74M +80.2% |
| EPS | 3.37 +83.4% |
| Shares Out | 53.79M |
| PE Ratio | 16.52 |
| Forward PE | 10.84 |
| Dividend | $0.98 (1.76%) |
| Ex-Dividend Date | Jul 30, 2026 |
| Volume | 356,728 |
| Open | 55.65 |
| Previous Close | 55.12 |
| Day's Range | 55.10 - 56.26 |
| 52-Week Range | 48.71 - 68.63 |
| Beta | 0.97 |
| Analysts | Strong Buy |
| Price Target | 73.29 (+31.58%) |
| Earnings Date | Jun 24, 2026 |
About FUL
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in va... [Read more]
Financial Performance
In fiscal year 2025, H.B. Fuller Company's revenue was $3.47 billion, a decrease of -2.67% compared to the previous year's $3.57 billion. Earnings were $151.97 million, an increase of 16.67%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for FUL stock is "Strong Buy." The 12-month stock price target is $73.29, which is an increase of 31.58% from the latest price.
News
H.B. Fuller Announces Quarterly Dividend
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, payable o...
H.B. Fuller price target raised to $72 from $70 at Deutsche Bank
Deutsche Bank raised the firm’s price target on H.B. Fuller (FUL) to $72 from $70 and keeps a Buy rating on the shares.
H.B. Fuller price target raised to $75 from $70 at Citi
Citi analyst Patrick Cunningham raised the firm’s price target on H.B. Fuller (FUL) to $75 from $70 and keeps a Buy rating on the shares.
H.B. Fuller price target lowered to $80 from $84 at Seaport Research
Seaport Research lowered the firm’s price target on H.B. Fuller (FUL) to $80 from $84 and keeps a Buy rating on the shares. The firm is lowering its price target…
H.B. Fuller upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded H.B. Fuller (FUL) to Overweight from Neutral with a price target of $67, up from $58. The company is rowing adjusted EBITDA via higher prices and positive currency…
H.B. Fuller Company Earnings Call Transcript: Q2 2026
Q2 saw strong revenue, EBITDA, and EPS growth, with margin expansion and robust cash flow. The announced AMS acquisition is expected to accelerate growth, expand the medical segment, and deliver significant synergies, while a disciplined deleveraging plan is in place.
H.B. Fuller Company Earnings release: Q2 2026
H.B. Fuller Company released its Q2 2026 earnings on June 25, 2026, summarizing the period's financial results.
H.B. Fuller Company Slides: Q2 2026
H.B. Fuller Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on June 25, 2026.
H.B. Fuller Company Quarterly report: Q2 2026
H.B. Fuller Company has published its Q2 2026 quarterly earnings report on June 25, 2026.
Ancora Holdings releases statement on H.B. Fuller, Advanced Medical Solutions
Ancora Holdings Group released the below statement regarding H.B. Fuller (FUL) Company and Advanced Medical Solutions Group. Previously, Ancora issued a letter to H.B. Fuller’s Board of Directors rega...
Ancora Condemns H.B. Fuller's Decision to Ignore Shareholder Opposition and Proceed with the Reckless Acquisition of Advanced Medical Solutions
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora” or “we”) today released the below statement regarding H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” ...
H.B. Fuller announces offer to acquire Advanced Medical Solutions for GBP 715M
H.B. Fuller (FUL) announced it has made a recommended cash offer to acquire Advanced Medical Solutions. Each eligible AMS shareholder will receive GBP 2.85 per share held in cash, which…
H.B. Fuller to buy UK's Advanced Medical Solutions for $942 million
U.S.-based adhesives maker H.B. Fuller will buy Advanced Medical Solutions Group in a cash deal that values the British medical supplier at about £715 million ($942.1 million) including debt, the co...
H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world's largest pureplay adhesives company, today announced it has made a recommended cash offer...
H.B. Fuller Reports Second Quarter 2026 Results
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today reported financial results for its second quarter that ended May 30, 2026. Second Quarter 2026 Noteworthy Items: Net revenue was...
Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Micron (MU), consensus $20.28… Jefferies (JEF), consensus $1.24… H.B. Fuller (FUL), consensus $1.38… MillerKnoll (M...
H.B. Fuller price target raised to $71 from $63 at UBS
UBS raised the firm’s price target on H.B. Fuller (FUL) to $71 from $63 and keeps a Neutral rating on the shares. The firm expects a beat and raise quarter,…
H.B. Fuller Sets 2030 Sustainability Targets, With Nearly 60% of Innovation Focused on Sustainable Solutions
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL), the world's largest pureplay adhesives company, today released its 2025 Sustainability Report, outlining 2030 environmental targets a...
H.B. Fuller to Report Second Quarter 2026 Results on June 24, 2026
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month fiscal period ended May 30, 2026, in a press release issued after ...
H.B. Fuller Advances Sustainable Packaging, Enhancing Barrier Coating Solutions, with VerdaFresh, New Advanced Oxygen Barrier Technology
VADNAIS HEIGHTS, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today announced a strategic investment in advanced oxygen barrier technology. VerdaFresh enhances the company's already strong ...
H.B. Fuller upgraded to Neutral from Underweight at JPMorgan
JPMorgan upgraded H.B. Fuller (FUL) to Neutral from Underweight with an unchanged price target of $58. The firm says the near-term share price performance may be determined by whether Fuller…
H.B. Fuller Issues Statement Regarding Value Creation Strategy
NEW YORK--(BUSINESS WIRE)--H.B. Fuller (NYSE: FUL) today issued the following statement: “Our Board and management team value the feedback of all shareholders and regularly engage with and listen to a...
Ancora urges H.B. Fuller to abandon acquisition of Advanced Medical Solutions
Ancora Holdings Group released a letter to H.B. Fuller (FUL) Company, which outlines the firm’s opposition to an acquisition of Advanced Medical Solutions Group or any other business. The letter…
Ancora Releases Letter Regarding its Strong Opposition to H.B. Fuller's High-Risk Attempt to Acquire U.K.-Based Advanced Medical Solutions
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC today released the below letter to H.B. Fuller Company (NYSE: FUL), which outlines the firm's strong opposition to an acquisition of Advanced Med...
UK's Advanced Medical Solutions gets fresh buyout bid from US-based H.B. Fuller
British medical supplier Advanced Medical Solutions on Thursday said it had received an unsolicited takeover proposal from U.S.-based adhesives maker H.B. Fuller , days after its last buyout talks...